Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Risedronic Acid Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Risedronic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 905Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Polpharma
    Poland
    		 PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard Gdanski PL R1-CEP 2013-126 - Rev 02 Risedronate sodium 2.5-hydrate 2022-05-09 Valid Chemical 2572
    26/09/2024 Aurobindo Pharma Limited
    India
    		 APITORIA PHARMA PRIVATE LIMITED Hyderabad IN CEP 2013-120 - Rev 02 Risedronate sodium 2.5-hydrate 2024-01-11 Valid Chemical 2572